Phenotypic screening of signaling motifs that efficiently induce cell proliferation.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
20 09 2023
20 09 2023
Historique:
received:
30
05
2023
accepted:
09
09
2023
medline:
22
9
2023
pubmed:
21
9
2023
entrez:
20
9
2023
Statut:
epublish
Résumé
Since cell proliferation is one of the fundamental cell fates, artificial control of cell proliferation based on a receptor-engineering approach is increasingly important in therapeutic and industrial applications. Since the signal transduction properties of cytokine receptors are greatly influenced by the amino acid sequence of tyrosine motifs, here we develop a phenotypic screening approach that can directly select cell proliferation-inducing tyrosine motifs from a synthetic library. In the tyrosine motif library, amino acid sequences around the tyrosine are randomized to attain diverse binding patterns of signaling molecules. Theoretically, engineered receptors with distinct tyrosine motifs would activate signaling molecules in diverse patterns. Thus, we investigated whether tyrosine motif sequences capable of inducing cell proliferation could be selected from the cellular library expressing the motif-engineered receptors. Consequently, the selected motifs induced similar levels of cell proliferation compared to the cytoplasmic signaling domain of a native receptor. The motif-screening system was applicable to cells that may differentiate or proliferate depending on cytokine signals. To our best knowledge, this is the first report demonstrating phenotypic screening of tyrosine motifs in living cells. Our approach would open up new possibilities in the field of artificial control of cell fate based on signal transduction engineering.
Identifiants
pubmed: 37730760
doi: 10.1038/s41598-023-42378-6
pii: 10.1038/s41598-023-42378-6
pmc: PMC10511696
doi:
Substances chimiques
Tyrosine
42HK56048U
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
15639Informations de copyright
© 2023. Springer Nature Limited.
Références
Kawahara, M. & Nagamune, T. Engineering of mammalian cell membrane proteins. Curr. Opin. Chem. Eng. 1, 411–417 (2012).
doi: 10.1016/j.coche.2012.05.002
Lipsitz, Y. Y., Timmins, N. E. & Zandstra, P. W. Quality cell therapy manufacturing by design. Nat. Biotechnol. 34, 393–400 (2016).
doi: 10.1038/nbt.3525
pubmed: 27054995
Kawahara, M., Ueda, H. & Nagamune, T. Engineering cytokine receptors to control cellular functions. BIochem. Eng. J. 48, 283–294 (2010).
doi: 10.1016/j.bej.2009.09.010
Ghanima, W., Cooper, N., Rodeghiero, F., Godeau, B. & Bussel, J. B. Thrombopoietin receptor agonists: Ten years later. Haematologica 104, 1112–1123 (2019).
doi: 10.3324/haematol.2018.212845
pubmed: 31073079
pmcid: 6545830
Harris, K. E. et al. A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells. Sci. Rep. 11, 10592 (2021).
doi: 10.1038/s41598-021-90096-8
pubmed: 34011961
pmcid: 8134639
Ito, K. et al. Single-chain tandem macrocyclic peptides as a scaffold for growth factor and cytokine mimetics. Commun. Biol. 5, 56 (2022).
doi: 10.1038/s42003-022-03015-6
pubmed: 35031676
pmcid: 8760323
Moraga, I. et al. Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands. Cell 160, 1196–1208 (2015).
doi: 10.1016/j.cell.2015.02.011
pubmed: 25728669
pmcid: 4766813
Ueki, R. et al. A chemically unmodified agonistic DNA with growth factor functionality for in vivo therapeutic application. Sci. Adv. 6, eaay2801 (2020).
doi: 10.1126/sciadv.aay2801
pubmed: 32270033
pmcid: 7112757
Ishizuka, S. et al. Designing motif-engineered receptors to elucidate signaling molecules important for proliferation of hematopoietic stem cells. ACS Synth. Biol. 7, 1709–1714 (2018).
doi: 10.1021/acssynbio.8b00163
pubmed: 29920201
Nakajima, K., Araki, S. & Kawahara, M. Tailoring minimal synthetic receptors to reconstitute signaling properties through multiple tyrosine motifs. Biochem. Biophys. Res. Commun. 566, 148–154 (2021).
doi: 10.1016/j.bbrc.2021.06.014
pubmed: 34126345
Saka, K., Kawahara, M. & Nagamune, T. Reconstitution of a cytokine receptor scaffold utilizing multiple different tyrosine motifs. Biotechnol. Bioeng. 110, 3197–3204 (2013).
doi: 10.1002/bit.24973
pubmed: 23775041
Saka, K., Kawahara, M., Ueda, H. & Nagamune, T. Activation of target signal transducers utilizing chimeric receptors with signaling-molecule binding motifs. Biotechnol. Bioeng. 109, 1528–1537 (2012).
doi: 10.1002/bit.24421
pubmed: 22228507
Larson, R. C. & Maus, M. V. Recent advances and discoveries in the mechanisms and functions of CAR T cells. Nat. Rev. Cancer 21, 145–161 (2021).
doi: 10.1038/s41568-020-00323-z
pubmed: 33483715
pmcid: 8353572
Kagoya, Y. et al. A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects. Nat. Med. 24, 352–359 (2018).
doi: 10.1038/nm.4478
pubmed: 29400710
pmcid: 5839992
Liu, B. A. et al. SH2 domains recognize contextual peptide sequence information to determine selectivity. Mol. Cell Proteomics 9, 2391–2404 (2010).
doi: 10.1074/mcp.M110.001586
pubmed: 20627867
pmcid: 2984226
Liu, B. A. et al. The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Mol. Cell 22, 851–868 (2006).
doi: 10.1016/j.molcel.2006.06.001
pubmed: 16793553
Pai, J. A. & Satpathy, A. T. High-throughput and single-cell T cell receptor sequencing technologies. Nat. Methods 18, 881–892 (2021).
doi: 10.1038/s41592-021-01201-8
pubmed: 34282327
pmcid: 9345561
Zhang, S. Q. et al. High-throughput determination of the antigen specificities of T cell receptors in single cells. Nat. Biotechnol. 36, 1156–1159 (2018).
doi: 10.1038/nbt.4282
Bloemberg, D. et al. A high-throughput method for characterizing novel chimeric antigen receptors in Jurkat cells. Mol. Ther. Methods Clin. Dev. 16, 238–254 (2020).
doi: 10.1016/j.omtm.2020.01.012
pubmed: 32083149
pmcid: 7021643
Vazquez-Lombardi, R. et al. High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity. Immunity 55, 1953–1966 (2022).
doi: 10.1016/j.immuni.2022.09.004
pubmed: 36174557
Kawahara, M. et al. Growth promotion of genetically modified hematopoietic progenitors using an antibody/c-Mpl chimera. Cytokine 55, 402–408 (2011).
doi: 10.1016/j.cyto.2011.05.024
pubmed: 21700475
Liu, W., Kawahara, M., Ueda, H. & Nagamune, T. Construction of a fluorescein-responsive chimeric receptor with strict ligand dependency. Biotechnol. Bioeng. 101, 975–984 (2008).
doi: 10.1002/bit.21961
pubmed: 18500765
Liu, W., Kawahara, M., Ueda, H. & Nagamune, T. The influence of domain structures on the signal transduction of chimeric receptors derived from the erythropoietin receptor. J. Biochem. 145, 575–584 (2009).
doi: 10.1093/jb/mvp013
pubmed: 19155265
Sogo, T. et al. Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera. J. Immunol. Methods 337, 16–23 (2008).
doi: 10.1016/j.jim.2008.05.003
pubmed: 18589435
Kongkrongtong, T., Sumigama, Y., Nagamune, T. & Kawahara, M. Reprogramming signal transduction through a designer receptor tyrosine kinase. Commun. Biol. 4, 752 (2021).
doi: 10.1038/s42003-021-02287-8
pubmed: 34140621
pmcid: 8211861
Kongkrongtong, T., Zhang, R. & Kawahara, M. Rational design of heterodimeric receptors capable of activating target signaling molecules. Sci. Rep. 11, 16809 (2021).
doi: 10.1038/s41598-021-96396-3
pubmed: 34413422
pmcid: 8376883
Guchhait, P., Tosi, M. F., Smith, C. W. & Chakaraborty, A. The murine myeloid cell line 32Dcl3 as a model system for studying neutrophil functions. J. Immunol. Methods 283, 195–204 (2003).
doi: 10.1016/j.jim.2003.09.013
pubmed: 14659911
Nakajima, K., Shen, Z., Miura, M., Nakabayashi, H. & Kawahara, M. Sequential control of myeloid cell proliferation and differentiation by cytokine receptor-based chimeric antigen receptors. PLoS ONE 17, e0279409 (2022).
doi: 10.1371/journal.pone.0279409
pubmed: 36574389
pmcid: 9794043
Smith, M. J., Hardy, W. R., Murphy, J. M., Jones, N. & Pawson, T. Screening for PTB domain binding partners and ligand specificity using proteome-derived NPXY peptide arrays. Mol. Cell Biol. 26, 8461–8474 (2006).
doi: 10.1128/MCB.01491-06
pubmed: 16982700
pmcid: 1636785
Wiederkehr-Adam, M. et al. Characterization of phosphopeptide motifs specific for the Src homology 2 domains of signal transducer and activator of transcription 1 (STAT1) and STAT3. J. Biol. Chem. 278, 16117–16128 (2003).
doi: 10.1074/jbc.M300261200
pubmed: 12591923
Numata, A. et al. Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway. J. Biol. Chem. 280, 12621–12629 (2005).
doi: 10.1074/jbc.M408442200
pubmed: 15664994
Nakabayashi, H., Kawahara, M. & Nagamune, T. Cell-surface expression levels are important for fine-tuning the performance of receptor tyrosine kinase-based signalobodies. Biotechnol. J. 12, 1700441 (2017).
doi: 10.1002/biot.201700441